AKAdama Kazienga

Adama Kazienga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adama Kazienga has a total of 265 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimal Long-Acting Antimalarial Regimens for Seasonal Malaria Chemoprevention: Mapping Review and Network Meta-Analysis

    by Dhruv Darji, Dhol Samuel Ayuen, Mary Scott, Boris Enock Zinsou, Adama Kazienga, Farhad Shorkraneh, Prabin Dahal, Philippe J. Guérin, James Watson

    Background: Over 50 million children receive seasonal malaria chemoprevention (SMC) each year with the combination of sulphadoxine-pyrimethamine (SP) plus amodiaquine (AQ). However, alternative chemoprevention regimens may be more effective due to drug resistance and more suitable pharmacokinetics. Methods: A systematic review was undertaken to identify all prospective efficacy and safety studies of malaria chemoprevention in children (WWARN ChemoMap). A Bayesian network meta-analysis (bNMA) was then conducted using randomised trials assessing antimalarial efficacy of SMC drug regimens. Regimens were grouped by their long-acting antimalarials and frequency of administration. The co-primary outcomes were incidence of uncomplicated malaria and severe malaria. Findings: The WWARN ChemoMap includes 150 studies and of these, 19 randomised trials of SMC were included in the bNMA. 18 trials were conducted in West Africa and one in East Africa (Uganda), and nine active antimalarial regimens were evaluated. For uncomplicated malaria, the combination of SPAQ plus seasonal RTS,S vaccination had the highest efficacy relative to no chemoprevention (incidence rate ratio [IRR] 0·07 [95% CrI 0·06-0·09]). This was followed by SP plus piperaquine (SPPQ; IRR 0·14 [95% CrI 0·04-0·22]), dihydroartemisinin plus piperaquine (DHAPQ; IRR 0·20 [95% CrI 0·16-0·23]), and SPAQ (IRR 0·25 [95% CrI 0·24-0·27]). The efficacy of SPAQ plus seasonal RTS,S was approximately multiplicative when compared with the individual effects of SPAQ and seasonal RTS,S. For severe malaria, the same combination (SPAQ plus seasonal RTS,S) also demonstrated greater efficacy (IRR 0·12 [95% CrI 0·06-0·28]) than SPAQ (IRR 0·42 [95% CrI 0·27-0·65]) and seasonal RTS,S (IRR 0·42 [95% CrI 0·22-0·79]). Interpretation: Combining SMC with seasonal malaria vaccination and using piperaquine-based regimens as an alternative to SPAQ could substantially increase its efficacy.

  • Open Access

    An intuitive sampling framework for setting-specific decision-making in soil-transmitted helminthiasis control programs

    by Adama Kazienga, Bruno Levecke, Sake J. de Vlas, Luc E. Coffeng

    Background: We recently developed a general egg count framework to support cost-efficient survey design choices to inform soil-transmitted helminthiasis (STH) control programs. Yet, the interpretation and the application was not always intuitive for program managers. Methods: We first adapted the existing framework to make the interpretation of risks of incorrect decision making more intuitive and to allow for prior information. Then, we assessed the impact of the allowable risk of incorrect decision-making and prior information on the required sample size. Finally, we determined the most cost-efficient survey design to inform the decisions (i) to switch to an event-based deworming program, and (ii) to declare STH eliminated as a public health problem (EPHP). Principal findings: The required sample sizes increased when the allowable risk of incorrect decision reduced and when the mean prior approached the program prevalence threshold. For the decisions to switch to event-based deworming and to declare EPHP, we found that duplicate Kato-Katz thick smears on a single stool sample was the most cost-efficient survey design, particularly when accounting for the added benefits of the free internal quality control. The required sample size for these survey designs varied between program targets and STH species. When aiming to have one sample size that fits all STHs, we recommend sampling 6 schools and 56 children per school for decisions on switching to event-based control programs and 11 schools (74 children per school) for the decision to declare EPHP. Conclusions/significance: We developed an intuitive sampling framework for setting-specific decision-making in STH control programs. We identified the most cost-efficient survey designs for critical program decisions, but these are based on subjective but reasonable choices regarding the risk of incorrect decision making. Reaching consensus within the STH community on acceptable levels of risk is crucial to further support evidence-based decision-making.

  • Open Access

    An intuitive sampling framework for setting-specific decision-making in soil-transmitted helminthiasis control programs

    by Adama Kazienga, Bruno Levecke, Sake J. de Vlas, Luc E. Coffeng

    Background: We recently developed a general egg count framework to support cost-efficient survey design choices to inform soil-transmitted helminthiasis (STH) control programs. Yet, the interpretation and the application was not always intuitive for program managers. Methods: We first adapted the existing framework to make the interpretation of risks of incorrect decision making more intuitive and to allow for prior information. Then, we assessed the impact of the allowable risk of incorrect decision-making and prior information on the required sample size. Finally, we determined the most cost-efficient survey design to inform the decisions (i) to switch to an event-based deworming program, and (ii) to declare STH eliminated as a public health problem (EPHP). Principal findings: The required sample sizes increased when the allowable risk of incorrect decision reduced and when the mean prior approached the program prevalence threshold. For the decisions to switch to event-based deworming and to declare EPHP, we found that duplicate Kato-Katz thick smears on a single stool sample was the most cost-efficient survey design, particularly when particularly when accounting for the added benefits of the free internal quality control. The required sample size for these survey designs varied between program targets and STH species. When aiming to have one sample size that fits all STHs, we recommend sampling 6 schools and 56 children per school for decisions on switching to event-based control programs and 11 schools (74 children per school) for the decision to declare EPHP. Conclusions/significance: We developed an intuitive sampling framework for setting-specific decision-making in STH control programs. We identified the most cost-efficient survey designs for critical program decisions, but these are based on subjective but reasonable choices regarding the risk of incorrect decision making. Reaching consensus within the STH community on acceptable levels of risk is crucial to further support evidence-based decision-making. Author summary: We recently developed a general computer simulation framework to support cost-efficient survey design choices for the control of intestinal worms. However, its interpretation was not always intuitive and it did not allow incorporation of prior knowledge on the prevalence of infections that programs might have. In this study, we adapted our framework to make the risks of incorrect decision-making more intuitive to interpret and to incorporate prior information on worm prevalence. We then quantified how different risk tolerances and prior prevalence assumptions affected required survey designs. Using this framework, we then identified the most cost-efficient survey designs for two key program decisions: switching to event-based deworming and declaring elimination of intestinal worms as a public health problem. We found that lower tolerance for incorrect decisions and greater uncertainty around prior prevalence substantially increase required sample sizes. Across the different program decisions and worm species, examining duplicate Kato–Katz thick smears from a single stool sample was consistently the most cost-efficient design, with the added benefit of internal quality control. Our results provide practical guidance for designing surveys tailored to local settings and highlight the importance of reaching consensus on acceptable levels of decision-making risk to support evidence-based STH control.

  • Open Access

    Target product profiles for new diagnostics to inform strongyloidiasis control programs

    by Adama Kazienga, Luc E. Coffeng, Sara Roose, Sake J. de Vlas, Dora Buonfrate, Salvatore Scarso, Francesca Tamarozzi, Bruno Levecke

    Background: The World Health Organization calls for the development of new diagnostics to support large-scale deworming programs against strongyloidiasis. To better steer research and development (R&D) of new diagnostics, it is imperative to identify the minimal requirements that new diagnostics should meet, the so-called target product profiles (TPPs). While diagnostic TPPs exist for other major soil-transmitted helminthiases, none exist for strongyloidiasis. Methods: We investigated a range of potential diagnostic TPPs using our previously developed simulation framework for the effect of imperfect diagnostics on the cost and correctness of program decisions. With this framework, we studied the minimum requirements for diagnostic performance, cost per test and sample throughput for future assays while comparing the survey costs with those of the reference Baermann method. As potential assay platforms, we considered antibody (Ab)-detecting assays, including a point-of-care lateral flow assay (LFA) and a laboratory-based Ab-ELISA. We also determined cost-efficient school-based survey designs for two currently available assays: Bordier Ab-ELISA and a prototype NIE-LFA. Principal findings: Our findings highlighted that (i) specificity rather than sensitivity is a critical parameter to consider for R&D of new diagnostic methods for monitoring control programs; (ii) the requirements for diagnostic performance became less stringent with an increasing sample size and when higher risks of incorrect decision-making were accepted. When focusing on the assay formats, the LFA resulted in lower survey costs compared to the Baermann method. Ab-ELISA was cost-efficient only if the diagnostic performance was nearly perfect combined with low cost per test and high sample throughput. Of all the three assays considered here, the prototype NIE-LFA allowed for the most cost-efficient survey designs. Conclusion/significance: R&D should focus on developing point-of-care assays with high specificity. The prototype NIE-LFA is a cost-efficient alternative to Baermann to support control programs for strongyloidiasis.


  • Open Access

    Target product profiles for new diagnostics to inform strongyloidiasis control programs

    by Adama Kazienga, Luc E. Coffeng, Sara Roose, Sake J de Vlas, Dora Buonfrate, Salvatore Scarso, Francesca Tamarozzi, Bruno Levecke

    Background: The World Health Organization calls for the development of new diagnostics to support large-scale deworming programs against strongyloidiasis. To better steer research and development (R&D) of new diagnostics, it is imperative to identify the minimal requirements that new diagnostics should meet, the so-called target product profiles (TPPs). While diagnostic TPPs exist for other major soil-transmitted helminthiases, none exist for strongyloidiasis. Methods: We investigated a range of potential diagnostic TPPs using our previously developed simulation framework for the effect of imperfect diagnostics on the cost and correctness of program decisions. With this framework, we studied the minimum requirements for diagnostic performance, cost per test and sample throughput for future assays while comparing the survey costs with those of the reference Baermann method. As potential assay platforms, we considered antibody (Ab)-detecting assays, including a point-of-care lateral flow assay (LFA) and a laboratory-based Ab-ELISA. We also determined cost-efficient school-based survey designs for two currently available assays: Bordier Ab-ELISA and a prototype NIE-LFA. Principal findings: Our findings highlighted that (i) specificity rather than sensitivity is a critical parameter to consider for R&D of new diagnostic methods for monitoring control programs; (ii) the requirements for diagnostic performance became less stringent with an increasing sample size and when higher risks of incorrect decision-making were accepted. When focusing on the assay formats, the LFA resulted in lower survey costs compared to the Baermann method. Ab-ELISA was cost-efficient only if the diagnostic performance was nearly perfect combined with low cost per test and high sample throughput. Of all the three assays considered here, the prototype NIE-LFA allowed for the most cost-efficient survey designs. Conclusion/significance: R&D should focus on developing point-of-care assays with high specificity. The prototype NIE-LFA is a cost-efficient alternative to Baermann to support control programs for strongyloidiasis. Author summary: The World Health Organization calls for the development of rapid, easy-to-use, and performant point-of-care diagnostics to follow up large-scale deworming programs against strongyloidiasis. However, there are no further recommendations regarding the required performance and cost of such new diagnostics. We performed a simulation study and a cost analysis to assess the minimum requirements in terms of diagnostic sensitivity and specificity, cost per test, and sample throughput for future assays while comparing the survey costs with those of a reference method. In addition, we determined the most cost-efficient survey designs to support control programs for strongyloidiasis applying currently available assays. Our results indicate that research & development efforts should focus on developing point-of-care assays with high specificity. Of the currently available diagnostics, a prototype of a rapid diagnostic test resulted in the lowest total survey cost, while restricting the risk of incorrect policy decisions to the minimum.

  • Open Access

    Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial

    by Paul Sondo, Bérenger Kaboré, Toussaint Rouamba, Eulalie Compaoré, Yssimini Nadège Guillène Tibiri, Hyacinthe Abd-El Latif Faïçal Kaboré, Karim Derra, Marc Christian Tahita, Hamidou Ilboudo, Gauthier Tougri, et al.

    Background: In rural African settings, most of the children under the coverage of Seasonal Malaria Chemoprevention (SMC) are also undernourished at the time of SMC delivery, justifying the need for packaging malarial and nutritional interventions. This study aimed at assessing the impact of SMC by coupling the intervention with nutrients supplementation for preventing malaria in children less than 5 years old in Burkina Faso.Methods: A randomized trial was carried out between July 2020 and June 2021 in the health district of Nanoro, Burkina Faso. Children (n = 1059) under SMC coverage were randomly assigned to one of the three study arms SMC + Vitamin A (SMC-A, n = 353) or SMC + Vitamin A + Zinc (SMC-AZc, n = 353) or SMC + Vitamin A + PlumpyDoz(tm) (SMC-APd, n = 353)-a medium quantity—lipid-based nutrient supplement (MQ-LNS). Children were followed up for one year that included an active follow-up period of 6 months with scheduled monthly home visits followed by 6 months passive follow-up. At each visit, capillary blood sample was collected for malaria diagnosis by rapid diagnosis test (RDT).Results: Adding nutritional supplements to SMC had an effect on the incidence of malaria. A reduction of 23% (adjusted IRR = 0.77 (95%CI 0.61–0.97) in the odds of having uncomplicated malaria in SMC-APd arm but not with SMC-AZc arm adjusted IRR = 0.82 (95%CI 0.65–1.04) compare to control arm was observed. A reduction of 52%, adjusted IRR = 0.48 (95%CI 0.23–0.98) in the odds of having severe malaria was observed in SMC-APd arm compared to control arm. Besides the effect on malaria, this combined strategy had an effect on all-cause morbidity. More specifically, a reduction of morbidity odds of 24%, adjusted IRR = 0.76 (95%CI 0.60–0.94) in SMC-APd arm compared to control arm was observed. Unlike clinical episodes, no effect of nutrient supplementation on cross sectional asymptomatic infections was observed.Conclusion: Adding nutritional supplements to SMC significantly increases the impact of this intervention for preventing children from malaria and other childhood infections.Trial registration: NCT04238845.


  • Open Access

    A comprehensive evaluation of an artificial intelligence based digital pathology to monitor large-scale deworming programs against soil-transmitted helminths: a study protocol

    by Peter K. Ward, Sara Roose, Mio Ayana, Lindsay A. Broadfield, Peter Dahlberg, Narcis Kabatereine, Adama Kazienga, Zeleke Mekonnen, Betty Nabatte, Lieven Stuyver, et al.

    Background Manual screening of a Kato-Katz (KK) thick stool smear remains the current standard to monitor the impact of large-scale deworming programs against soil-transmitted helminths (STHs). To improve this diagnostic standard, we recently designed an artificial intelligence based digital pathology system (AI-DP) for digital image capture and analysis of KK thick smears. Preliminary results of its diagnostic performance are encouraging, and a comprehensive evaluation of this technology as a cost-efficient end-to-end diagnostic to inform STH control programs against the target product profiles (TPP) of the World Health Organisation (WHO) is the next step for validation. Methods Here, we describe the study protocol for a comprehensive evaluation of the AI-DP based on its (i) diagnostic performance, (ii) repeatability/reproducibility, (iii) time-to-result, (iv) cost-efficiency to inform large-scale deworming programs, and (v) usability in both laboratory and field settings. For each of these five attributes, we designed separate experiments with sufficient power to verify the non-inferiority of the AI-DP (KK2.0) over the manual screening of the KK stool thick smears (KK1.0). These experiments will be conducted in two STH endemic countries with national deworming programs (Ethiopia and Uganda), focussing on school-age children only. Discussion This comprehensive study will provide the necessary data to make an evidence-based decision on whether the technology is indeed performant and a cost-efficient end-to-end diagnostic to inform large-scale deworming programs against STHs. Following the protocolized collection of high-quality data we will seek approval by WHO. Through the dissemination of our methodology and statistics, we hope to support additional developments in AI-DP technologies for other neglected tropical diseases in resource-limited settings. Trial registration The trial was registered on Clinicaltrials.gov (ID: NCT06055530). Author summary Millions of deworming tablets are annually administered to children to reduce the morbidity caused by intestinal worms. To monitor the progress of these large-scale deworming programs, periodic assessments are made regarding the occurrence and prevalence of intestinal worm infections. Manual examination of a stool smear through a compound microscope remains the current diagnostic standard. We recently developed a device that utilizes artificial intelligence (AI) to scan smears and recognize eggs of intestinal worms. Encouraging preliminary results of the diagnostic performance warrant additional and more research, essential for obtaining necessary approvals to support wide-scale adoption. Here, we describe the study protocols we will employ for a comprehensive evaluation of this AI-based device. The generated results will provide health decision-makers with evidence-based data to assess whether the tool can be recommended for informing large-scale deworming programs against intestinal worms. Additionally, we provide full access to our study documentation which may be relevant for evaluating other AI-based devices for intestinal worms.

  • Open Access

    Growth of Gram-Negative Bacteria in Antiseptics, Disinfectants and Hand Hygiene Products in Two Tertiary Care Hospitals in West Africa—A Cross-Sectional Survey

    by Palpouguini Lompo, Anne-Sophie Heroes, Esenam Agbobli, Adama Kazienga, Marjan Peeters, Halidou Tinto, Katrien Lagrou, Lassana Sangaré, Dissou Affolabi, Jan Jacobs

    Antiseptics, disinfectants, and hand hygiene products can act as reservoirs of Gram-negative bacteria causing healthcare-associated infections. This problem is rarely documented in low- and middle-income countries, particularly in sub-Saharan Africa. In a cross-sectional survey, we assessed the bacterial contamination of antiseptics, disinfectants, and hand hygiene products in two university hospitals in Burkina Faso and Benin. During ward visits and staff interviews, in-use products were cultured for the presence of Gram-negative bacteria. The growth of Gram-negative bacteria was absent or rare in alcohol-based products, povidone iodine, and Dakin solution. Contamination was highest (73.9% (51/69)) for liquid soap products (versus antiseptic/disinfectants (4.5%, 7/157) (p < 0.0001)), mostly used in high-risk areas and associated with high total bacterial counts (>10,000 colony-forming units/mL). Contaminating flora (105 isolates) included Enterobacterales and the Vibrio non-cholerae/Aeromonas group (17.1%) and non-fermentative Gram-negative rods (82.8%). Multidrug resistance was present among 9/16 Enterobacterales (Klebsiella and Enterobacter spp.) and 3/12 Acinetobacter spp., including carbapenem resistance (Acinetobacter baumannii: NDM, Pseudomonas stutzeri: VIM). The risk factors for contamination included the type of product (cleaning grade and in-house prepared liquid soap), use of recycled disposable containers and soft drink bottles, absence of labeling, topping-up of containers, dilution with tap water (pharmacy and ward), and poor-quality management (procurement, stock management, expiry dates, and period after opening).


  • Open Access

    A general framework to support cost-efficient survey design choices for the control of soil-transmitted helminths when deploying Kato-Katz thick smear

    by Adama Kazienga, Bruno Levecke, Gemechu Tadesse Leta, Sake J. de Vlas, Luc E. Coffeng

    Background: To monitor and evaluate soil-transmitted helminth (STH) control programs, the World Health Organization (WHO) recommends screening stools from 250 children, deploying Kato-Katz thick smear (KK). However, it remains unclear whether these recommendations are sufficient to make adequate decisions about stopping preventive chemotherapy (PC) (prevalence of infection <2%) or declaring elimination of STHs as a public health problem (prevalence of moderate-to-heavy intensity (MHI) infections <2%). Methodology: We developed a simulation framework to determine the effectiveness and cost of survey designs for decision-making in STH control programs, capturing the operational resources to perform surveys, the variation in egg counts across STH species, across schools, between and within individuals, and between repeated smears. Using this framework and a lot quality assurance sampling approach, we determined the most cost-efficient survey designs (number of schools, subjects, stool samples per subject, and smears per stool sample) for decision-making. Principal findings: For all species, employing duplicate KK (sampling 4 to 6 schools and 64 to 70 subjects per school) was the most cost-efficient survey design to assess whether prevalence of any infection intensity was above or under 2%. For prevalence of MHI infections, single KK was the most cost-efficient (sampling 11 to 25 schools and 52 to 84 children per school). Conclusions/Significance: KK is valuable for monitoring and evaluation of STH control programs, though we recommend deploying a duplicate KK on a single stool sample to stop PC, and a single KK to declare the elimination of STHs as a public health problem.


  • Open Access

    A general framework to support cost-efficient survey design choices for the control of soil-transmitted helminths when deploying Kato-Katz thick smear

    by Adama Kazienga, Bruno Levecke, Gemechu Tadesse Leta, Sake J. de Vlas, Luc E. Coffeng

    Background To monitor and evaluate soil-transmitted helminth (STH) control programs, the World Health Organization (WHO) recommends screening stools from 250 children across 5 schools, deploying Kato-Katz thick smear (KK). However, it remains unclear whether these recommendations are sufficient to make adequate decisions about stopping preventive chemotherapy (PC) (prevalence of infection Methodology We developed a simulation framework to determine the effectiveness and cost of survey designs for decision-making in STH control programs, capturing the operational resources to perform surveys, the variation in egg counts across STH species, across schools, between and within individuals, and between repeated smears. Using this framework and a lot quality assurance sampling approach, we determined the most cost-efficient survey designs (number of schools, subjects, stool samples per subject, and smears per stool sample) for decision-making. Principal findings For all species, employing duplicate KK (sampling 4 to 6 schools and 64 to 70 subjects per school) was the most cost-efficient survey design to assess whether prevalence of any infection intensity was above or under 2%. For prevalence of MHI infections, single KK was the most cost-efficient (sampling 11 to 25 schools and 52 to 84 children per school). Conclusions/Significance KK is valuable for monitoring and evaluation of STH control programs, though we recommend to deploy a duplicate KK on a single stool sample to stop PC, and a single KK to declare the elimination of STH as a public health problem. Author summary Worldwide large-scale deworming programs are implemented to reduce the morbidity attributable to intestinal worms in school children. To monitor and evaluate the progress towards the programs goals, Word Health Organization (WHO) has developed both a survey design and a corresponding decision tree based on the prevalence and intensity of infections. However, these programs operate in resource-constrained countries, and hence it is crucial to minimize the operational costs to survey worm infections while ensuring the correctness of the program decision. To further support WHO in more evidence-based recommendations for cost-efficient decision-making, we developed a general framework that captures both the operational resources to perform surveys and the variation in test results when deploying the current diagnostic standard. Subsequently, we determined the most cost-efficient survey design to decide to stop the deworming programs and to verify whether the morbidity attributable to intestinal worms has been eliminated as a public health problem. Generally, we found that the current WHO-recommended survey design may not allow for optimal decision making. Based on our results, we proposed alternative survey designs for each of the worm species and program targets.